David G Martin

Title: The Innovative Contributions of David G. Martin

Introduction

David G. Martin is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential antitumor activity. With a total of seven patents to his name, Martin's work has garnered attention in both academic and industrial circles.

Latest Patents

One of Martin's latest patents involves CC-1065 analogs. This invention focuses on 2-acyl-4,5,8,8a-tetrahydro-4-oxycyclopropan[c]pyrrol(3,2-e) indole derivatives, which are useful as UV light absorber substances, chemical intermediates, and prodrugs of known spirocyclopropylpyrroloindole CC-1065 analogs. The compounds of this formula have demonstrated promising antitumor activity in standard laboratory animal tests. Another significant patent is the purification of AT-125, which details a process for purifying L-(.alpha.S,5S)-.alpha.-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125). This patent also includes AT-125 analogs prepared during the purification process.

Career Highlights

David G. Martin is associated with The Upjohn Company, where he has been able to apply his innovative ideas in a practical setting. His work has contributed to advancements in pharmaceutical chemistry, particularly in the development of therapeutic agents.

Collaborations

Throughout his career, Martin has collaborated with notable colleagues, including Ladislav J. Hanka and Robert C. Kelly. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

David G. Martin's contributions to the field of chemistry and his innovative patents reflect his dedication to advancing scientific knowledge and developing new therapeutic solutions. His work continues to influence the industry and inspire future innovations.